Graham Capital Management L.P. acquired a new stake in Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 142,401 shares of the biopharmaceutical company’s stock, valued at approximately $678,000. Graham Capital Management L.P. owned […]
Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) has earned an average recommendation of “Hold” from the twenty ratings firms that are currently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, thirteen have issued a hold recommendation and five have assigned a buy recommendation to the company. […]
Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) has been assigned an average rating of “Hold” from the twenty analysts that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, thirteen have given a hold recommendation and five have assigned a buy recommendation to the company. […]
Shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) have received a consensus rating of “Hold” from the twenty brokerages that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have assigned a buy rating […]
Acadian Asset Management LLC Purchases Shares of 912,917 Fate Therapeutics, Inc (NASDAQ:FATE) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.